We are live on ! Find out more
MHC

Meyer Handelman Company Portfolio holdings

AUM $3.22B
1-Year Est. Return 24.51%
This Fund
S&P 500
This Quarter Est. Return
-10.88%
1 Year Est. Return
+24.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+95.69%
10 Year Est. Return
+272.81%
AUM
$1.77B
AUM Growth
-$280M
Cap. Flow
-$31.5M
Cap. Flow %
-1.78%
Top 10 Hldgs %
29.68%
Holding
198
New
5
Increased
27
Reduced
79
Closed
9

Top Buys

Rank Stock Value
1
REZI icon
Resideo Technologies
REZI
+$2.17M
2
GILD icon
Gilead Sciences
GILD
+$1.89M
3
CAG icon
Conagra Brands
CAG
+$950K
4
DD icon
DuPont de Nemours
DD
+$893K
5
CI icon
Cigna
CI
+$675K

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$4.54M
2
PFE icon
Pfizer
PFE
+$2.92M
3
DUK icon
Duke Energy
DUK
+$2.45M
4
SHPG
Shire pic
SHPG
+$2.43M
5
PG icon
Procter & Gamble
PG
+$2.11M

Sector Composition

Rank Sector Weight
1 Consumer Staples 17.75%
2 Healthcare 17.74%
3 Industrials 17.51%
4 Technology 15.3%
5 Energy 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMA
126
DELISTED
Comerica
CMA
$1.28M 0.07%
18,631
ILF icon
127
iShares Latin America 40 ETF
ILF
$3.79B
$1.16M 0.07%
37,736
SYF icon
128
Synchrony
SYF
$25.1B
$1.13M 0.06%
48,082
-1,314
-3% -$35.5K
DXC icon
129
DXC Technology
DXC
$1.76B
$1.06M 0.06%
20,036
-214
-1% -$14.8K
FTV icon
130
Fortive
FTV
$19.5B
$1.06M 0.06%
24,897
ZTS icon
131
Zoetis
ZTS
$32.5B
$1.01M 0.06%
11,828
META icon
132
Meta Platforms (Facebook)
META
$1.51T
$996K 0.06%
7,600
-1,232
-14% -$178K
BSX icon
133
Boston Scientific
BSX
$68.5B
$932K 0.05%
26,400
EMN icon
134
Eastman Chemical
EMN
$7.79B
$841K 0.05%
11,500
+3,500
+44% +$279K
KMPR icon
135
Kemper
KMPR
$1.82B
$828K 0.05%
12,475
-1,005
-7% -$73.3K
LMT icon
136
Lockheed Martin
LMT
$134B
$778K 0.04%
2,972
+600
+25% +$182K
FMS icon
137
Fresenius Medical Care
FMS
$13.3B
$777K 0.04%
24,000
RDS.A
138
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$722K 0.04%
12,392
AVNS icon
139
Avanos Medical
AVNS
$701K 0.04%
15,635
-1,500
-9% -$78.6K
EW icon
140
Edwards Lifesciences
EW
$48.2B
$674K 0.04%
13,200
YUM icon
141
Yum! Brands
YUM
$41.4B
$666K 0.04%
7,250
BABA icon
142
Alibaba
BABA
$276B
$657K 0.04%
4,792
+2,890
+152% +$427K
HWM icon
143
Howmet Aerospace
HWM
$114B
$649K 0.04%
50,233
-4,179
-8% -$65.3K
CDK
144
DELISTED
CDK Global, Inc.
CDK
$610K 0.03%
12,730
+500
+4% +$26.4K
AVY icon
145
Avery Dennison
AVY
$12.9B
$602K 0.03%
6,700
NVT icon
146
nVent Electric
NVT
$22.9B
$598K 0.03%
26,590
-1,500
-5% -$36.3K
SI
147
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$585K 0.03%
10,500
-2,156
-17% -$120K
VWO icon
148
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$571K 0.03%
15,000
ADBE icon
149
Adobe
ADBE
$99B
$566K 0.03%
2,500
VEA icon
150
Vanguard FTSE Developed Markets ETF
VEA
$225B
$556K 0.03%
15,000

Similar funds

Meyer Handelman Company's Q4 2018 Portfolio in Review

As of Q4 2018, Meyer Handelman Company held 198 positions worth $1.77B, down 14% from $2.05B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Meyer Handelman Company's Q4 2018 filing shows 5 new, 27 increased, 79 reduced and 9 closed positions. Its largest new stake was Resideo Technologies: 101,630 shares worth $2.09M. The largest sale was Honeywell, an estimated $4.54M.

By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Meyer Handelman Company's largest Q4 2018 buy was Resideo Technologies: 101,630 shares worth $2.09M.
  • Meyer Handelman Company added most to Gilead Sciences in Q4 2018, an estimated $1.89M increase.
  • Meyer Handelman Company's biggest Q4 2018 reduction was Honeywell, cutting an estimated $4.54M.
  • Meyer Handelman Company fully exited Shire pic in Q4 2018, selling an estimated $2.43M.
  • Meyer Handelman Company's ten largest holdings make up 30% of its $1.77B portfolio in Q4 2018.
  • Meyer Handelman Company opened 5 new positions and closed 9 in Q4 2018.
  • Meyer Handelman Company's portfolio value fell 14% quarter-over-quarter to $1.77B.

Based on Meyer Handelman Company's 13F filing for Q4 2018, filed 5 Feb 2019.